Wealth Enhancement Advisory Services, LLC Trans Medics Group, Inc. Transaction History

Wealth Enhancement Advisory Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Mar 17, 2025	SELL	$59.28 - $144.9 $34,975 - $85,491	-590 Reduced 14.66%	3,435 $214,000
Q4 2024 Jan 10, 2025	BUY	$59.28 - $144.9 $6,283 - $15,359	106 Added 2.7%	4,025 $250,000
Q3 2024 Oct 23, 2024	SELL	$135.68 - $176.11 $48,980 - $63,575	-361 Reduced 8.43%	3,919 $615,000
Q2 2024 Jul 16, 2024	SELL	$72.62 - $150.62 $56,353 - $116,881	-776 Reduced 15.35%	4,280 $644,000
Q1 2024 Apr 15, 2024	BUY	$70.86 - $89.93 $358,268 - $454,686	5,056 New	5,056 $373,000

343

30M

671K

858K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.9B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.